Resistance Training and Corticospinal Excitability in Multiple Sclerosis - Trial NCT06374108
Access comprehensive clinical trial information for NCT06374108 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Aarhus and is currently Not yet recruiting. The study focuses on Multiple Sclerosis. Target enrollment is 54 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Aarhus
Timeline & Enrollment
N/A
May 01, 2024
May 31, 2026
Primary Outcome
MEP/Mmax ratio
Summary
The goal of the present study is to investigate effects of progressive resistance training on
 central nervous system functioning (corticospinal excitability (CSE)) and walking capacity in
 persons with multiple sclerosis (pwMS). A total of 54 pwMS will be enrolled and randomized
 into 1 of 3 groups: high dose resistant training (RT), low dose RT, and waitlist control.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06374108
Non-Device Trial